Professor / MD
ORCID – ResearcherID
(+33)
List of publications :
Cazzato, R. L., Garnon, J., De Marini, P., Auloge, P., Dalili, D., Koch, G., Antoni, D., Barthelemy, P., Kurtz, J. E., Malouf, G., Feydy, A., Charles, Y.-P., & Gangi, A. (2020). French Multidisciplinary Approach for the Treatment of MSK Tumors. Seminars in Musculoskeletal Radiology, 24(3), 310–322. https://doi.org/10.1055/s-0040-1710052
Pfisterer, J., Shannon, C. M., Baumann, K., Rau, J., Harter, P., Joly, F., Sehouli, J., Canzler, U., Schmalfeldt, B., Dean, A. P., Hein, A., Zeimet, A. G., Hanker, L. C., Petit, T., Marmé, F., El-Balat, A., Glasspool, R., de Gregorio, N., Mahner, S., … AGO-OVAR 2.21/ENGOT-ov 18 Investigators. (2020). Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial. The Lancet. Oncology. https://doi.org/10.1016/S1470-2045(20)30142-X
You, B., Robelin, P., Tod, M., Louvet, C., Lotz, J.-P., Abadie-Lacourtoisie, S., Fabbro, M., Desauw, C., Bonichon-Lamichhane, N., Kurtz, J.-E., Follana, P., Leheurteur, M., Del Piano, F., Ferron, G., DE Rauglaudre, G., Ray-Coquard, I., Combe, P., Chevalier Place, A., Joly, F., … Colomban, O. (2020). CA-125 ELIMination rate constant K (KELIM) Is A Marker Of Chemosensitivity In Patients With Ovarian Cancer: Results from the Phase II CHIVA trial. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.CCR-20-0054
Herrscher, H., Bronnec, M., Antoni, D., Ghnassia, J.-P., Magnenet, P., Kurtz, J.-E., & Noël, G. (2020). Successful treatment of primary cutaneous angiosarcoma of the nose with sequential chemo- and radiotherapy. Clinical and Translational Radiation Oncology, 21, 1–4. https://doi.org/10.1016/j.ctro.2019.11.001
Bender, L., Gantzer, J., Somme, F., Weingertner, N., & Kurtz, J.-E. (2020). Complete Response of a Pleural, Hepatic, and Splenic Metastatic Primary Breast Angiosarcoma Using Gemcitabine Monotherapy. JCO Oncology Practice, JOP1900609. https://doi.org/10.1200/JOP.19.00609
Herrscher, H., Boilève, A., Lindner, V., Barthélémy, P., Hutt, É., Pierard, L., Kurtz, J.-E., Rioux-Leclercq, N., Lang, H., & Malouf, G. G. (2020). [MiT family translocation renal cell carcinomas: Natural history, molecular features and multidisciplinary management]. Bulletin Du Cancer. https://doi.org/10.1016/j.bulcan.2019.11.010
Kurtz, J.-E., Gantzer, J., Garnon, J., & Gangi, A. (2019). [Loco-regional therapy for desmoid tumeurs. Current status and perspectives]. Bulletin Du Cancer. https://doi.org/10.1016/j.bulcan.2019.10.012
Basse, C., Italiano, A., Penel, N., Mir, O., Chemin, C., Toulmonde, M., Duffaud, F., Le Cesne, A., Chevreau, C., Maynou, C., Anract, P., Gouin, F., Rios, M., Firmin, N., Kurtz, J.-E., Kerbrat, P., Piperno-Neumann, S., Bertucci, F., Rosset, P., … Blay, J.-Y. (2019). Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 years. International Journal of Cancer, 145(8), 2135–2143. https://doi.org/10.1002/ijc.32307
Gantzer, J., Di Marco, A., Fabacher, T., Weingertner, N., Delhorme, J.-B., Brinkert, D., Bierry, G., Ghnassia, J.-P., Jégu, J., & Kurtz, J.-E. (2019). Conformity to Clinical Practice Guidelines at Initial Management in Adult Soft Tissue and Visceral Tumors since the Implementation of the NetSarc Network in Eastern France. The Oncologist, 24(8), e775–e783. https://doi.org/10.1634/theoncologist.2018-0751
Rousset-Jablonski, C., Selle, F., Adda-Herzog, E., Planchamp, F., Selleret, L., Pomel, C., Daraï, E., Chabbert-Buffet, N., Pautier, P., Trémollières, F., Guyon, F., Rouzier, R., Laurence, V., Chopin, N., Faure-Conter, C., Bentivegna, E., Vacher-Lavenu, M.-C., Lhomme, C., Floquet, A., … Ray-Coquard, I. (2019). Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers. European Journal of Cancer (Oxford, England: 1990), 116, 35–44. https://doi.org/10.1016/j.ejca.2019.04.018
Malouf, G. G., Beinse, G., Adam, J., Mir, O., Chamseddine, A. N., Terrier, P., Honore, C., Spano, J.-P., Italiano, A., Kurtz, J.-E., Coindre, J.-M., Blay, J.-Y., & Le Cesne, A. (2019). Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group. The Oncologist, 24(7), 980–988. https://doi.org/10.1634/theoncologist.2018-0074
Joly, F., Ahmed-Lecheheb, D., Kalbacher, E., Heutte, N., Clarisse, B., Grellard, J. M., Gernier, F., Berton-Rigaud, D., Tredan, O., Fabbro, M., Savoye, A. M., Kurtz, J. E., Alexandre, J., Follana, P., Delecroix, V., Dohollou, N., Roemer-Becuwe, C., De Rauglaudre, G., Lortholary, A., … Pautier, P. (2019). Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 30(5), 845–852. https://doi.org/10.1093/annonc/mdz074
Herrscher, H., Artzner, T., Severac, F., Faitot, F., Kurtz, J.-E., Janssen-Langenstein, R., Maestraggi, Q., Schneider, F., & Michard, B. (2019). Intensive care for patients with gastric cancers: outcome and survival prognostic factors. Journal of Gastrointestinal Oncology, 10(2), 292–299. https://doi.org/10.21037/jgo.2018.10.11
Lange, M., Heutte, N., Noal, S., Rigal, O., Kurtz, J.-E., Lévy, C., Allouache, D., Rieux, C., Lefel, J., Clarisse, B., Leconte, A., Veyret, C., Barthélémy, P., Longato, N., Tron, L., Castel, H., Eustache, F., Giffard, B., & Joly, F. (2019). Cognitive Changes After Adjuvant Treatment in Older Adults with Early-Stage Breast Cancer. The Oncologist, 24(1), 62–68. https://doi.org/10.1634/theoncologist.2017-0570
Denouel, A., Heutte, N., Escudier, B., Kurtz, J.-E., Santos, M. D., Longato, N., Desrues, L., Dauchy, S., Lange, M., Sevin, E., Rieux, C., Clarisse, B., Castel, H., Noal, S., & Joly, F. (2018). Sexual Disorders of Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Antiangiogenic Therapies. Clinical Genitourinary Cancer, 16(5), 369-375.e1. https://doi.org/10.1016/j.clgc.2018.05.013
Imperiale, A., Latgé, A., Schaff-Wendling, F., Goichot, B., Kurtz, J.-E., & Malouf, G. G. (2018). Metabolic Response to BRAF-MEK Combination Therapy in Cecal Neuroendocrine Carcinoma With BRAFV600E Mutation and Refractory Lactic Acidosis. Clinical Nuclear Medicine, 43(9), 701–702. https://doi.org/10.1097/RLU.0000000000002231
Bompas, E., Campion, L., Italiano, A., Le Cesne, A., Chevreau, C., Isambert, N., Toulmonde, M., Mir, O., Ray-Coquard, I., Piperno-Neumann, S., Saada-Bouzid, E., Rios, M., Kurtz, J.-E., Delcambre, C., Dubray-Longeras, P., Duffaud, F., Karanian, M., Le Loarer, F., Soulié, P., … Blay, J.-Y. (2018). Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study. Cancer Medicine, 7(8), 4023–4035. https://doi.org/10.1002/cam4.1374
Trensz, P., Calvel, L., & Kurtz, J. E. (2018). The hard road to patient-centered care: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer? Annals of Oncology: Official Journal of the European Society for Medical Oncology, 29(7), 1601. https://doi.org/10.1093/annonc/mdy186
Lorcet, M., Lortholary, A., Kurtz, J. E., Berton-Rigaud, D., Fabbro, M., De La Motte Rouge, T., Kaminsky-Forrett, M. C., Floquet, A., Freyer, G., Combe, P., Dohollou, N., Kalbacher, E., Despax, R., Largillier, R., Hardy Bessard, A. C., Gane, N., Sehouli, J., Oskay-Oezcelik, G., Licaj, I., … Joly Lobbedez, F. (2018). [Expectation about maintenance therapy among the GINECO French ovarian cancer cohort from the European NOGGO/ENGOT-ov22 Expression IV survey]. Bulletin Du Cancer, 105(5), 465–474. https://doi.org/10.1016/j.bulcan.2018.01.015
Oskay-Özcelik, G., Alavi, S., Richter, R., Keller, M., Chekerov, R., Cecere, S. C., Cormio, G., Joly, F., Kurtz, J. E., du Bois, A., Maciejewski, M., Jedryka, M., Vergote, I., Van Nieuwenhuysen, E., Casado, A., Mendiola, C., Achimas-Cadariu, P., Vlad, C., Reimer, D., … Sehouli, J. (2018). Expression III: patients’ expectations and preferences regarding physician-patient relationship and clinical management-results of the international NOGGO/ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countries. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 29(4), 910–916. https://doi.org/10.1093/annonc/mdy037
Rousset-Jablonski, C., Selle, F., Adda-Herzog, E., Planchamp, F., Selleret, L., Pomel, C., Chabbert-Buffet, N., Daraï, E., Pautier, P., Trémollières, F., Guyon, F., Rouzier, R., Laurence, V., Chopin, N., Faure-Conter, C., Bentivegna, E., Vacher-Lavenu, M.-C., Lhomme, C., Floquet, A., … Ray-Coquard, I. (2018). [Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer]. Bulletin Du Cancer, 105(3), 299–314. https://doi.org/10.1016/j.bulcan.2017.10.032
Walter, T., Malka, D., Hentic, O., Lombard-Bohas, C., Le Malicot, K., Smith, D., Ferru, A., Assenat, E., Cadiot, G., Lievre, A., Kurtz, J.-E., Dahan, L., Dubreuil, O., Hautefeuille, V., Lepere, C., Gangloff, A., Elhajbi, F., Coriat, R., Roquin, G., … Lepage, C. (2018). Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41-BEVANEC randomized phase II study. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 50(2), 195–198. https://doi.org/10.1016/j.dld.2017.11.020
Blay, J.-Y., Soibinet, P., Penel, N., Bompas, E., Duffaud, F., Stoeckle, E., Mir, O., Adam, J., Chevreau, C., Bonvalot, S., Rios, M., Kerbrat, P., Cupissol, D., Anract, P., Gouin, F., Kurtz, J.-E., Lebbe, C., Isambert, N., Bertucci, F., … Le Cesne, A. (2017). Improved survival using specialized multidisciplinary board in sarcoma patients. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 28(11), 2852–2859. https://doi.org/10.1093/annonc/mdx484